Bristol-Myers Squibb launched TAXOL (paclitaxel)

, , , ,

In 1993, Bristol-Myers Squibb launched TAXOL (paclitaxel). The company invested hundreds of millions of dollars to supply TAXOL for clinical trials, prepare data for regulatory submission and develop alternative sources of TAXOL.

TAXOL is derived from the bark of the endangered Pacific Yew tree.

Tags:


Source: National Cancer Institute
Credit:

Advertise in our E-history sent to 5,000 plus company decision makers twice per month for only $300 per month. Reserve your space now! E-mail: info@LifeScienceHistory.com.